For citations:
Ignatova E.O., Frolova M.A., Petrovsky A.B., Stenina M.B., Glazkova E.V., Krokhina O.V., Tjulandin C.A. EVALUATION OF EFFICACY AND TOXICITY OF NEOADJUVANT CHEMOTHERAPY WITH DOSE-DENSE DOXORUBICIN, CISPLATIN, AND PACLITAXEL IN PATIENTS WITH EARLY TRIPLE-NEGATIVE BREAST CANCER. Malignant tumours. 2016;(4):49-57. (In Russ.) https://doi.org/10.18027/2224-5057-2016-4-49-57
Email this article 